ArticleMolecules (Basel, Switzerland)2023

Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen.

Antonios D Tsiailanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.